Titlebook: Anti-Angiogenic Therapy in Ophthalmology; Andreas Stahl Book 2016 Springer International Publishing Switzerland 2016 Age-related macular d

complicated

書目名稱Anti-Angiogenic Therapy in Ophthalmology影響因子(影響力)




書目名稱Anti-Angiogenic Therapy in Ophthalmology影響因子(影響力)學(xué)科排名




書目名稱Anti-Angiogenic Therapy in Ophthalmology網(wǎng)絡(luò)公開度




書目名稱Anti-Angiogenic Therapy in Ophthalmology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Anti-Angiogenic Therapy in Ophthalmology被引頻次




書目名稱Anti-Angiogenic Therapy in Ophthalmology被引頻次學(xué)科排名




書目名稱Anti-Angiogenic Therapy in Ophthalmology年度引用




書目名稱Anti-Angiogenic Therapy in Ophthalmology年度引用學(xué)科排名




書目名稱Anti-Angiogenic Therapy in Ophthalmology讀者反饋




書目名稱Anti-Angiogenic Therapy in Ophthalmology讀者反饋學(xué)科排名

腫塊

歡樂中國

Retinal Vascular Development,evelopment is of interest for translational researchers and clinicians in order to develop preventive and interventional therapeutics for vascular eye diseases. In addition, the study of retinal vascular development has attracted significant interest in basic angiogenesis research due to high access

阻礙

小母馬

978-3-319-79580-5Springer International Publishing Switzerland 2016

Ibd810

Anti-Angiogenic Therapy in Ophthalmology978-3-319-24097-8Series ISSN 1612-3212 Series E-ISSN 2196-890X

全國性

parallelism

https://doi.org/10.1007/978-3-540-69289-8 and developed world despite current screening and treatment guidelines. Originally named “retrolental fibroplasia,” ROP was first connected to premature birth in the 1940s and slightly later to oxygen supplementation in these premature infants. Today, an ever-improving understanding of ROP pathomec

暴發(fā)戶

Andreas StahlExplains why anti-angiogenic therapy is effective for various ocular diseases.Highlights the advantages and limitations of anti-angiogenic therapy.Written by established experts in their respective fi

挑剔為人